Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck

British Journal of Dermatology

Volumn 159, Issue 5, 2008, Pages 1186-1191

  Sassi, F ^a   Cazzaniga, S ^a,b   Tessari, G ^c   Chatenoud, L ^d   Reseghetti, A ^a   Marchesi, L ^a   Girolomoni, G ^c   Naldi, L ^a  

^a OSPEDALI RIUNITI   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Excimer laser; Phototherapy; Randomized controlled trial; Topical corticosteroids; Vitiligo

Indexed keywords

HYDROCORTISONE BUTYRATE; STEROID;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHEMA; EXCIMER LASER; FACE; FEMALE; HUMAN; HYPERPIGMENTATION; HYPERTRICHOSIS; MAJOR CLINICAL STUDY; MALE; NECK; PHOTOTHERAPY; PHYSICIAN GLOBAL ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SKIN ATROPHY; SKINDEX 29; TREATMENT FAILURE; TREATMENT OUTCOME; VITILIGO;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; COMBINED MODALITY THERAPY; DERMATOLOGIC AGENTS; FACIAL DERMATOSES; FEMALE; HUMANS; HYDROCORTISONE; LASERS, EXCIMER; MALE; MIDDLE AGED; NECK; QUALITY OF LIFE; TREATMENT OUTCOME; VITILIGO; YOUNG ADULT;

EID: 54249160608     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08793.x     Document Type: Article

References (24)

1. Howitz J, Brodthagen H, Schwartz M, Thomsen K. Prevalence of vitiligo: epidemiological survey on the isle of Bornholm, Denmark. Arch Dermatol 1977 113 : 47 52.
2. Johnson M-LT, Roberts J. Skin Conditions and Related Need for Medical Care among Persons 1-74 Years. Publication No. (PHS) 79-1660. Hyattsville, MD : U.S. Department of Health, Education and Welfare, 1978.
3. Das S, Majumder P, Chakraborty R et al. Studies on vitiligo. I. Epidemiological profile in Calcutta, India. Genet Epidemiol 1985 2 : 71 8.
4. Naldi L, Colombo P, Placchesi EB et al. Study design and preliminary results from the pilot phase of the PraKtis study: self-reported diagnoses of selected skin diseases in a representative sample of the Italian population. Dermatology 2004 208 : 38 42.
5. Le Poole IC, Wankowicz-Kalinska A, van den Wijngaard RM et al. Autoimmune aspects of depigmentation in vitiligo. J Investig Dermatol Symp Proc 2004 9 : 68 72.
6. Kent G, Al'Abadie M. Psychologic effects of vitiligo: a critical incident analysis. J Am Acad Dermatol 1996 35 : 895 8.
7. Whitton ME, Ashcroft DM, Barrett CW, Gonzalez U. Interventions for vitiligo. Cochrane Database Syst Rev 2006 1 : CD003263.
8. Njoo MD, Westerhof W, Bos JD, Bossuyt PM. The development of guidelines for the treatment of vitiligo. Arch Dermatol 1999 135 : 1514 21.
9. Bónis B, Kemény L, Dobozy A et al. 308 nm UVB excimer laser for psoriasis. Lancet 1997 350 : 1522.
10. Baltas E, Nagy P, Bonis B et al. Repigmentation of localised vitiligo with the xenon chloride laser. Br J Dermatol 2001 144 : 1266 7.
11. Nijsten T, Meads DM, de Korte J et al. Cross-cultural inequivalence of dermatology-specific health-related quality of life instruments in psoriasis patients. J Invest Dermatol 2007 127 : 2315 22.
12. Westerhof W, Nieuweboer-Krobotova L, Mulder PG, Glazenburg EJ. Left-right comparison study of the combination of fluticasone propionate and UV-A vs. either fluticasone propionate or UV-A alone for the long-term treatment of vitiligo. Arch Dermatol 1999 135 : 1061 6.
13. Chow J, Tron VA. Molecular aspects of ultraviolet radiation-induced apoptosis in the skin. J Cutan Med Surg 2005 9 : 289 95.
14. Novák Z, Bónis B, Baltás E et al. Xenon chloride ultraviolet B laser is more effective in treating psoriasis and in inducing T cell apoptosis than narrow-band ultraviolet. J Photochem Photobiol B 2002 67 : 32 8.
15. Baltas E, Csoma Z, Ignacz F et al. Treatment of vitiligo with the 308-nm xenon chloride excimer laser. Arch Dermatol 2002 138 : 1619 20.
16. Spencer JM, Nossa R, Ajmeri J. Treatment of vitiligo with the 308-nm excimer laser: a pilot study. J Am Acad Dermatol 2002 46 : 727 31.
17. Taneja A, Trehan M, Taylor CR. 308-nm excimer laser for the treatment of localized vitiligo. Int J Dermatol 2003 42 : 658 62.
18. Passeron T, Ostovari N, Zakaria W et al. Topical tacrolimus and the 308-nm excimer laser. Arch Dermatol 2004 140 : 1065 9.
19. Lim HW, Hexsel CL. Vitiligo. To treat or not to treat. Arch Dermatol 2007 143 : 643 6.
20. Arca E, Tastan HB, Erbil AH et al. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo. J Dermatol 2006 33 : 338 43.
21. Ermis O, Alpsoy E, Cetin L, Yilmaz E. Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo controlled double-blind study. Br J Dermatol 2001 145 : 472 5.
22. Goldinger SM, Dummer R, Schmid P et al. Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo. J Eur Acad Dermatol Venereol 2007 21 : 504 8.
23. Lewis VJ, Finlay AW. A critical review of quality-of-life scales for psoriasis. Dermatol Clin 2005 23 : 707 16.
24. Sampogna F, Tabolli S, Abeni D, IDI Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) investigators. The impact of changes in clinical severity on psychiatric morbidity in patients with psoriasis: a follow-up study. Br J Dermatol 2007 157 : 508 13.